Author:
Pilch Nicole A.,Meadows Holly B.,Alloway Rita R.
Publisher
Springer International Publishing
Reference89 articles.
1. Alexion Pharmaceuticals: Eculizumab (Soliris) Package Insert. Alexion Pharmaceuticals, Cheshire. Last updated: 2011
2. Amlot PL, Rawlings E, Fernando ON, Griffin PJ, Heinrich G, Schreier MH, Castaigne JP, Moore R, Sweny P (1995) Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation. Transplantation 60:748–756
3. Bloom DD, Hu H, Fechner JH, Knechtle SJ (2006) T-lymphocyte alloresponses of Campath-1H treated kidney transplant patients. Transplantation 81:81–87
4. Bristol Myers Squibb Company: Belatacept (Nulojix) Package Insert. Bristol Myers Squibb, Princeton. Last updated: June 2011
5. Buysmann S, Bemelman FJ, Schellekens PT, van Kooyk Y, Figdor CG, ten Berge IJ (1996) Activation and increased expression of adhesion molecules on peripheral blood lymphocytes is a mechanism for the immediate lymphocytopenia after administration of OKT3. Blood 87:404–411
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical Post-Transplant Lymphoproliferative Disorders;Cardiovascular & Hematological Disorders-Drug Targets;2022-06